Enhancing 5-Fluorouracil Efficacy in a Primary Colorectal Cancer by Long-lasting Calcium Supplementation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeong, Keun-Yeong | - |
dc.contributor.author | Park, Minhee | - |
dc.contributor.author | Kim, In Un | - |
dc.contributor.author | Sim, Jae Jun | - |
dc.contributor.author | Kim, Hwan Mook | - |
dc.date.available | 2020-02-27T18:42:45Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-06 | - |
dc.identifier.issn | 0250-7005 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/6077 | - |
dc.description.abstract | Background/Aim: 5-Fluorouracil (5-FU) over-use has led to an urgent need for alternative treatment regimens, such as a lower concentration of the drug because of its toxic effects. The aim of this study was to investigate the possibility of improving the antitumor effect of 5-FU without toxicity by targeting primary colorectal cancer (CRC) with sustained calcium supplementation. Materials and Methods: The viability of CRC cells was determined after treatment of 5-FU, lactate calcium salt (CaLac), or the combination of te two. Western blot analysis for the focal adhesion kinase (FAK) signaling cascade was performed to investigate the underlying mechanism. A xenograft model was established to evaluate antitumor efficacy of each treatment, and the necrotic effect was also observed in tumor tissues. Results: By the combined treatment, proteolysis of FAK signaling cascade, was mediated by sustained calcium supplementation resulting in further decrease in the clonogenicity of CRC cells. The in vivo anticancer efficacy including tumor necrosis was significantly increased by the combination treatment compared to single treatment of with 5-FU. Conclusion: Sustained calcium supplementation was able to enhance the potency of 5-FU targeting the primary CRC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | INT INST ANTICANCER RESEARCH | - |
dc.relation.isPartOf | ANTICANCER RESEARCH | - |
dc.subject | COLON-CANCER | - |
dc.subject | VITAMIN-D | - |
dc.subject | RISK | - |
dc.subject | MECHANISMS | - |
dc.subject | ADHESION | - |
dc.title | Enhancing 5-Fluorouracil Efficacy in a Primary Colorectal Cancer by Long-lasting Calcium Supplementation | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000402181600023 | - |
dc.identifier.doi | 10.21873/anticanres.11649 | - |
dc.identifier.bibliographicCitation | ANTICANCER RESEARCH, v.37, no.6, pp.2959 - 2964 | - |
dc.identifier.scopusid | 2-s2.0-85019712775 | - |
dc.citation.endPage | 2964 | - |
dc.citation.startPage | 2959 | - |
dc.citation.title | ANTICANCER RESEARCH | - |
dc.citation.volume | 37 | - |
dc.citation.number | 6 | - |
dc.contributor.affiliatedAuthor | Kim, In Un | - |
dc.contributor.affiliatedAuthor | Sim, Jae Jun | - |
dc.contributor.affiliatedAuthor | Kim, Hwan Mook | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Primary colorectal cancer | - |
dc.subject.keywordAuthor | 5-FU | - |
dc.subject.keywordAuthor | lactate salt | - |
dc.subject.keywordAuthor | focal adhesion kinase | - |
dc.subject.keywordAuthor | epithelial-mesenchymal transition | - |
dc.subject.keywordAuthor | combination treatment | - |
dc.subject.keywordPlus | COLON-CANCER | - |
dc.subject.keywordPlus | VITAMIN-D | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | ADHESION | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.